MESO
Mesoblast limited.

5,282
Mkt Cap
$2.36B
Volume
254,164.00
52W High
$21.50
52W Low
$9.61
PE Ratio
-21.64
MESO Fundamentals
Price
$16.89
Prev Close
$18.30
Open
$17.63
50D MA
$18.16
Beta
1.43
Avg. Volume
223,729.50
EPS (Annual)
-$0.8443
P/B
3.92
Rev/Employee
$211,960.04
$1,281.89
Loading...
Loading...
News
all
press releases
Mesoblast Touts High Survival Rates For FDA-Approved Cell Therapy
Mesoblast shares fall after new Ryoncil data show high survival in severe GVHD. Company plans adult trial as analysts keep Hold rating and stock trades near key levels.read more...
Benzinga·23h ago
News Placeholder
More News
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's Why
Mesoblast (NASDAQ:MESO) Shares Gap Up - Should You Buy...
MarketBeat·4d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Share Price Passes Below 50-Day Moving Average - Time to Sell?
Mesoblast (NASDAQ:MESO) Shares Cross Below 50-Day Moving Average - Should You Sell...
MarketBeat·6d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Pass Below Fifty Day Moving Average - Here's Why
Mesoblast (NASDAQ:MESO) Share Price Crosses Below 50-Day Moving Average - Here's Why...
MarketBeat·14d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Cross Below 50 Day Moving Average - Here's What Happened
Mesoblast (NASDAQ:MESO) Stock Price Crosses Below 50-Day Moving Average - Here's What Happened...
MarketBeat·23d ago
News Placeholder
FDA Signals Support For Mesoblast's Cell Therapy For Chronic Back Pain
Mesoblast says FDA feedback supports filing plans for its cell therapy to treat chronic back pain, showing reduced pain and lower opioid use in a late-stage trial.read more...
Benzinga·24d ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?
Mesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Mesoblast Chair Jane Bell To Retire; Appoints Philip Facchina As Non-executive Chair
(RTTNews) - Mesoblast Limited (MESO, MSB.AX) announced that Jane Bell will retire from her role as Chair and will remain on the Board as a non-executive director. The Board has unanimously appointed...
Nasdaq News: Markets·1mo ago
News Placeholder
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy PR Newswire VANCOUVER, BC, Dec. 16, 2025 Issued on behalf of Avant...
PR Newswire·2mo ago
News Placeholder
Mesoblast (NASDAQ:MESO) Shares Gap Up - What's Next?
Mesoblast (NASDAQ:MESO) Shares Gap Up - Here's What Happened...
MarketBeat·2mo ago
<
1
2
...
>

Latest MESO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.